In Reversal, F.D.A. Delays Push for Shots for Children Under 5

The agency will wait for data on whether three doses of Pfizer-BioNTech’s Covid vaccine are effective in young children after new, disappointing data.

Related Keywords

Boston ,Massachusetts ,United States ,Arkansas ,Washington ,Americans ,American ,Malia Jones ,Normanw Baylor ,Peter Marks ,Rachel Perera ,James Conway ,Jessica Snowden ,Los Angeles ,Kristin Moffitt ,University Of Wisconsin ,American Academy Of Pediatrics ,Centers For Disease ,Pfizer ,Drug Administration ,Kaiser Family Foundation ,Harvard Medical School ,Disease Control ,American Academy ,East Coast ,Coronavirus Pandemic ,Key Things ,Ofer Levy ,Boston Children ,Arkansas Children ,Kaiser Family ,Biontech ,Children ,Fda ,Omicron Variant ,Vaccines Immunization ,Coronavirus Covid 19 Pandemic ,Pharmaceuticals Prescription Drugs ,Clinical Trial ,